Project I Test: Implementing HIV Testing in Opioid Treatment Programs (NCT03135886)
A Cluster RCT to Increase HIV Testing in Substance Use Treatment Programs
๐ฉบ Plain-English Summary (8th-Grade Level)
This study will test two active evidence-based "practice coaching" (PC) interventions to improve opioid treatment programs' (OTPs') provision and sustained implementation of on-site 1) HIV testing and linkage to care and 2) HIV/Hepatitis C virus (HCV) testing and linkage to care among patients seeking/receiving substance use disorder treatment. Aims are: Aim 1: To evaluate the effectiveness of the PC interventions on improving patient uptake of HIV testing in OTPs including the incremental impact of the HIV/HCV intervention on HIV testing. Aim 2: To examine, using mixed-methods, the impact of the PC interventions on the initiation and sustained provision of HIV testing and timely linkage to care. Aim 3: To evaluate the health outcomes, health care utilization, and cost-effectiveness of the PC interventions compared incrementally to one another and to the control condition. Primary Hypothesis: 1. The two PC interventions will result in significantly higher proportions of patients tested for HIV than the information control condition during the "initial impact" period (7-12 months post-randomization or T3), controlling for the proportion of patients tested during the baseline period, T1 (Primary) and during the "sustained impact" period, 13-18 months post-randomization or T4 (Secondary). 2. The HIV/HCV PC intervention will result in significantly higher proportions of patients tested for HIV than the HIV PC intervention during the initial impact period (7-12 months post-randomization or T3), controlling for the proportion of patients tested during the baseline period, T1 (Secondary) and during the "sustained impact" period, 13-18 months post-randomization or T4 (Secondary).
Who can join: Review the eligibility criteria below.
Location: Columbia University Medical Center โ New York, New York
Age range: 18 Years
๐งช Interventions in This Study
- Information Control (OTHER)
- HIV and HCV Testing Practice Coaching Intervention (OTHER)
- HIV Testing Practice Coaching Intervention (OTHER)
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- Columbia University Medical Center โ New York, New York
๐ Contact the Study Coordinator
Phone: (786) 703-9819
Email: lkg2129@columbia.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in HIV/AIDS
- Optimizing Tobacco Use Treatment for PLWHA โ Chicago, Illinois
- Intervention for Virologic Suppression in Youth โ San Francisco, California
- ResIlience-based Stigma REdUction Program ("Rise-up") โ Columbia, South Carolina
- Effects of Semaglutide in HIV-Associated Lipohypertrophy โ Cleveland, Ohio
- Robot-Assisted Rehabilitation After HIV-Associated Stroke: Botswana โ Philadelphia, Pennsylvania
- The Dreamer Girls Project: Adaptation of SISTA/SIHLE for HIV/AIDS and Substance Abuse Prevention Among Black Adolescent Girls โ Paterson, New Jersey
Explore by condition: All HIV/AIDS clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.